Cargando…

Establishment of three heterogeneous subtypes and a risk model of low-grade gliomas based on cell senescence-related genes

BACKGROUND: Cellular senescence is a key element in the occurrence and progression of a variety of tumors. As a result, cellular senescence-related markers can be categorized based on the prognosis status of patients. Due to the heterogeneity and the complexity of the tumor microenvironment (TME), t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jing, Wu, Lingjiao, Yang, Hanjin, Zhang, XiaoChen, Xv, SuZhen, Qian, Qiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424930/ https://www.ncbi.nlm.nih.gov/pubmed/36052073 http://dx.doi.org/10.3389/fimmu.2022.982033

Ejemplares similares

Establishment and validation of a novel prognostic model for lower-grade glioma based on senescence-related genes
por: Li, Junsheng, et al.
Publicado: (2022)

Heterogeneity in clinical prognosis, immune infiltration and molecular characteristics of three glycolytic subtypes in lower-grade gliomas
por: Wu, Shenglian, et al.
Publicado: (2023)

Identification of Methylation Immune Subtypes and Establishment of a Prognostic Signature for Gliomas Using Immune-Related Genes
por: Hu, Zhengang, et al.
Publicado: (2021)

Subtype and grade-dependent spatial heterogeneity of T-cell infiltration in pediatric glioma
por: Robinson, M Hope, et al.
Publicado: (2020)

Identification of senescence-related subtypes, establishment of a prognosis model, and characterization of a tumor microenvironment infiltration in breast cancer
por: Zhou, Yanling, et al.
Publicado: (2022)

Identification of heterogeneous subtypes and a prognostic model for gliomas based on mitochondrial dysfunction and oxidative stress-related genes
por: Li, Junsheng, et al.
Publicado: (2023)

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
por: Zhang, Hongbo, et al.
Publicado: (2020)

Identification of Implications of Angiogenesis and m6A Modification on Immunosuppression and Therapeutic Sensitivity in Low-Grade Glioma by Network Computational Analysis of Subtypes and Signatures
por: Li, Bo, et al.
Publicado: (2022)

Six Immune Associated Genes Construct Prognostic Model Evaluate Low-Grade Glioma
por: Tan, Yin Qiu, et al.
Publicado: (2020)

Identification of cell senescence molecular subtypes in prediction of the prognosis and immunotherapy of hepatitis B virus-related hepatocellular carcinoma
por: Yu, Xue, et al.
Publicado: (2022)

Molecular Subtypes of Glioblastoma Are Relevant to Lower Grade Glioma
por: Guan, Xiaowei, et al.
Publicado: (2014)

Prognostic value of γ‐aminobutyric acidergic synapse-associated signature for lower-grade gliomas
por: Jiang, Hongxiang, et al.
Publicado: (2022)

Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma
por: Cai, Jiayang, et al.
Publicado: (2022)

Prognostic Gene Expression Signature in Patients With Distinct Glioma Grades
por: Ait Ssi, Saadia, et al.
Publicado: (2021)

Tenascin-C can Serve as an Indicator for the Immunosuppressive Microenvironment of Diffuse Low-Grade Gliomas
por: Zhang, Po, et al.
Publicado: (2022)

Identification of pyroptosis-related subtypes and establishment of prognostic model and immune characteristics in asthma
por: Yang, Fan, et al.
Publicado: (2022)

TGF-β Signaling Promotes Glioma Progression Through Stabilizing Sox9
por: Chao, Min, et al.
Publicado: (2021)

Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine
por: Zhong, Hua, et al.
Publicado: (2021)

Subtyping of gliomas of various WHO grades by the application of immunohistochemistry
por: Popova, Svetlana N, et al.
Publicado: (2014)

Pediatric versus adult high grade glioma: Immunotherapeutic and genomic considerations
por: Aggarwal, Payal, et al.
Publicado: (2022)

PLEKHA4 is a novel prognostic biomarker that reshapes the tumor microenvironment in lower-grade glioma
por: Zhi, Wenqian, et al.
Publicado: (2023)

Identification of immunotherapy and chemotherapy-related molecular subtypes in colon cancer by integrated multi-omics data analysis
por: Zhu, Jie, et al.
Publicado: (2023)

Recognition of Tumor-Associated Antigens and Immune Subtypes in Glioma for mRNA Vaccine Development
por: Ma, Shuai, et al.
Publicado: (2021)

Crosstalk of RNA Adenosine Modification-Related Subtypes, Establishment of a Prognostic Model, and Immune Infiltration Characteristics in Ovarian Cancer
por: Ni, Xiaoge, et al.
Publicado: (2022)

Identification of molecular subtypes based on inflammatory response in lower-grade glioma
por: Lin, Wanzun, et al.
Publicado: (2022)

Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy
por: Teng, Chubei, et al.
Publicado: (2022)

Oncolytic immunovirotherapy for high-grade gliomas: A novel and an evolving therapeutic option
por: Asija, Sweety, et al.
Publicado: (2023)

Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma
por: Xu, Shengchao, et al.
Publicado: (2021)

CAR-T Therapy for Pediatric High-Grade Gliomas: Peculiarities, Current Investigations and Future Strategies
por: Antonucci, Laura, et al.
Publicado: (2022)

Positive regulators of T cell functions as predictors of prognosis and microenvironment characteristics of low-grade gliomas
por: Li, Yang, et al.
Publicado: (2023)

Patient-derived xenografts of different grade gliomas retain the heterogeneous histological and genetic features of human gliomas
por: Zeng, Wenxin, et al.
Publicado: (2020)

Establishment of patient-derived organoid models of lower-grade glioma
por: Abdullah, Kalil G, et al.
Publicado: (2021)

Crosstalk of angiogenesis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in colorectal adenocarcinoma
por: Cui, Guoliang, et al.
Publicado: (2022)

Construction of a novel molecular typing and scoring system for anoikis distinguishes between different prognostic risks and treatment responsiveness in low-grade glioma
por: Zhang, Ganghua, et al.
Publicado: (2023)

SAMD9 Is Relating With M2 Macrophage and Remarkable Malignancy Characters in Low-Grade Glioma
por: Ma, Wenping, et al.
Publicado: (2021)

Significance of NotchScore and JAG1 in predicting prognosis and immune response of low-grade glioma
por: Shi, Bo, et al.
Publicado: (2023)

RNA N1-methyladenosine regulator-mediated methylation modification patterns and heterogeneous signatures in glioma
por: Mao, Meng, et al.
Publicado: (2022)

Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas
por: Salloum, Ralph, et al.
Publicado: (2017)

Characterizing temporal genomic heterogeneity in pediatric low-grade gliomas
por: Lazow, Margot A., et al.
Publicado: (2020)

T2 mapping of molecular subtypes of WHO grade II/III gliomas
por: Kern, Maike, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_muv75f21r6an2qgpo4rc093nsc